| 1 |
Dickins, R. A., McJunkin, K., Hernando, E., Premsrirut, P. K., Krizhanovsky, V., Burgess, D. J., Kim, S. Y., Cordon-Cardo, C., Zender, L. and Hannon, G. J. (2007) Tissue-specifi c and reversible RNA interference in transgenic mice. Nat. Genet. 39, 914-921.
DOI
ScienceOn
|
| 2 |
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B. and Herman, J. G. (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N. Engl. J. Med. 343, 1350-1354.
DOI
ScienceOn
|
| 3 |
Frese, K. K. and Tuveson, D. A. (2007) Maximizing mouse cancer models. Nat. Rev. Cancer 7, 645-658.
|
| 4 |
Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W. and Bujard, H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
DOI
|
| 5 |
Hansen, K. and Khanna, C. (2004) Spontaneous and genetically engineered animal models: use in preclinical cancer drug development. Eur. J. Cancer 40, 858-880.
DOI
ScienceOn
|
| 6 |
Hoefl ich, K. P., Gray, D. C., Eby, M. T., Tien, J. Y., Wong, L., Bower, J., Gogineni, A., Zha, J., Cole, M. J. and Stern, H. M. (2006) Oncogenic BRAF is required for tumor growth and maintenance in melanoma models. Cancer Res. 66, 999-1006.
DOI
ScienceOn
|
| 7 |
Jaisser, F. (2000) Inducible gene expression and gene modification in transgenic mice. J. Am. Soc. Nephrol. 11, S95-S100.
|
| 8 |
Jonkers, J. and Berns, A. (2002) Conditional mouse models of sporadic cancer. Nat. Rev. Cancer 2, 251-265.
DOI
ScienceOn
|
| 9 |
Kats, L. M., Reschke, M., Taulli, R., Pozdnyakova, O., Burgess, K., Bha rgava, P., Straley, K., Karnik, R., Meissner, A. and Small, D. (2014) Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance. Cell Stem Cell 14, 329-341.
DOI
ScienceOn
|
| 10 |
Kleinhammer, A., Deussing, J., Wurst, W. and Kuhn, R. (2011a) Conditional RNAi in mice. Methods 53, 142-150.
DOI
ScienceOn
|
| 11 |
Kleinhammer, A., Wurst, W. and Kuhn, R. (2011b) Constitutive and conditional RNAi transgenesis in mice. Methods 53, 430-436.
DOI
ScienceOn
|
| 12 |
Kleinhammer, A., Wurst, W. and Kuhn, R. (2013) Target validation in mice by constitutive and conditional RNAi. Methods Mol. Biol. 986, 307-323.
DOI
ScienceOn
|
| 13 |
Abate-Shen, C. (2006) A new generation of mouse models of cancer for translational research. Clin. Cancer Res. 12, 5274-5276.
DOI
ScienceOn
|
| 14 |
Beard, C., Hochedlinger, K., Plath, K., Wutz, A. and Jaenisch, R. (2006) Efficient method to generate single-copy transgenic mice by site-specifi c integration in embryonic stem cells. Genesis 44, 23-28.
DOI
ScienceOn
|
| 15 |
Begley, C. G. and Ellis, L. M. (2012) Drug development: Raise standards for preclinical cancer research. Nature 483, 531-533.
DOI
ScienceOn
|
| 16 |
Belteki, G., Haigh, J., Kabacs, N., Haigh, K., Sison, K., Costantini, F., Whitsett, J., Quaggin, S. E. and Nagy, A. (2005) Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res. 33, e51.
DOI
ScienceOn
|
| 17 |
Bolon, B. (2004) Genetically engineered animals in drug discovery and development: a maturing resource for toxicologic research. Basic Clin. Pharmacol. Toxicol. 95, 154-161.
|
| 18 |
Boxer, R. B., Jang, J. W., Sintasath, L. and Chodosh, L. A. (2004) Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell 6, 577-586.
DOI
ScienceOn
|
| 19 |
Coumoul, X. and Deng, C. X. (2006) RNAi in mice: a promising approach to decipher gene functions in vivo. Biochimie 88, 637-643.
DOI
ScienceOn
|
| 20 |
Carmell, M. A., Zhang, L., Conklin, D. S., Hannon, G. J. and Rosenquist, T. A. (2003) Germline transmission of RNAi in mice. Nat. Struct. Biol. 10, 91-92.
DOI
ScienceOn
|
| 21 |
Coumoul, X., Shukla, V., Li, C., Wang, R. H. and Deng, C. X. (2005) Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. Nucleic Acids Res. 33, e102.
DOI
ScienceOn
|
| 22 |
Svoboda, P., Stein, P. and Schultz, R. M. (2001) RNAi in mouse oocytes and preimplantation embryos: effectiveness of hairpin dsRNA. Biochem. Biophys. Res. Commun. 287, 1099-1104.
DOI
ScienceOn
|
| 23 |
Strathdee, D., Ibbotson, H. and Grant, S. G. (2006) Expression of transgenes targeted to the Gt(ROSA)26Sor locus is orientation dependent. PLoS One 1, e4.
DOI
|
| 24 |
Suggitt, M. and Bibby, M. C. (2005) 50 years of preclinical anticancer drug screening: empirical to target-driven approaches. Clin. Cancer Res. 11, 971-981.
|
| 25 |
Sun, Y., Chen, X. and Xiao, D. (2007) Tetracycline-inducible expression systems: new strategies and practices in the transgenic mouse modeling. Acta Biochim.Biophys. Sin. 39, 235-246.
DOI
ScienceOn
|
| 26 |
van der Weyden, L., White, J. K., Adams, D. J. and Logan, D. W. (2011) The mouse genetics toolkit: revealing function and mechanism. Genome Biol. 12, 224.
DOI
|
| 27 |
Ventura, A., Meissner, A., Dillon, C. P., McManus, M., Sharp, P. A., Van Parijs, L., Jaenisch, R. and Jacks, T. (2004) Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. U.S.A. 101, 10380-10385.
DOI
ScienceOn
|
| 28 |
Wong, A. K. and Chin, L. (2000) An inducible melanoma model implicates a role for RAS in tumor maintenance and angiogenesis. Cancer Metastasis Rev. 19, 121-129.
DOI
ScienceOn
|
| 29 |
Zambrowicz, B. P. and Sands, A. T. (2003) Knockouts model the 100 best-selling drugs--will they model the next 100? Nat. Rev. Drug Discov. 2, 38-51.
DOI
ScienceOn
|
| 30 |
Zuber, J., McJunkin, K., Fellmann, C., Dow, L. E., Taylor, M. J., Hannon, G. J. and Lowe, S. W. (2011a) Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi. Nat. Biotechnol. 29, 79-83.
DOI
ScienceOn
|
| 31 |
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., Taylor, M. J., Johns, C., Chicas, A., Mulloy, J. C., Kogan, S. C., Brown, P., Valent, P., Bradner, J. E., Lowe, S. W. and Vakoc, C. R. (2011b) RNAi screen identifi es Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478, 524-528.
DOI
ScienceOn
|
| 32 |
Reinert, R. B., Kantz, J., Misfeldt, A. A., Poffenberger, G., Gannon, M., Brissova, M. and Powers, A. C. (2012) Tamoxifen-induced CreloxP recombination is prolonged in pancreatic islets of adult mice. PLoS One 7, e33529.
DOI
|
| 33 |
Richmond, A. and Su, Y. (2008) Mouse xenograft models vs GEM models for human cancer therapeutics. Dis. Model. Mech. 1, 78-82.
DOI
ScienceOn
|
| 34 |
Robles, A. I. and Varticovski, L. (2008) Harnessing genetically engineered mouse models for preclinical testing. Chem. Biol. Interact. 171, 159-164.
DOI
ScienceOn
|
| 35 |
Rubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., Sievers, C., Yang, L., Kopinja, J., Rooney, D. L., Zhang, M., Ihrig, M. M. and McManus, M. T. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33, 401-406.
DOI
ScienceOn
|
| 36 |
Seibler, J., Kuter-Luks, B., Kern, H., Streu, S., Plum, L., Mauer, J., Kuhn, R., Bruning, J. C. and Schwenk, F. (2005) Single copy shRNA confi guration for ubiquitous gene knockdown in mice. Nucleic Acids Res. 33, e67.
DOI
ScienceOn
|
| 37 |
Soriano, P. (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71.
DOI
ScienceOn
|
| 38 |
Seibler, J., Kleinridders, A., Kuter-Luks, B., Niehaves, S., Bruning, J. C. and Schwenk, F. (2007) Reversible gene knockdown in mice using a tight, inducible shRNA expression system. Nucleic Acids Res. 35, e54.
DOI
ScienceOn
|
| 39 |
Sharpless, N. E. and Depinho, R. A. (2006) The mighty mouse: genetically engineered mouse models in cancer drug development. Nat. Rev. Drug Discov. 5, 741-754.
DOI
ScienceOn
|
| 40 |
Singh, M. and Johnson, L. (2006) Using genetically engineered mouse models of cancer to aid drug development: an industry perspective. Clin. Cancer Res. 12, 5312-5328.
DOI
ScienceOn
|
| 41 |
Sotillo, R., Hernando, E., Diaz-Rodriguez, E., Teruya-Feldstein, J., Cordon-Cardo, C., Lowe, S. W. and Benezra, R. (2007) Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11, 9-23.
DOI
ScienceOn
|
| 42 |
Sotillo, R., Schvartzman, J. M., Socci, N. D. and Benezra, R. (2010) Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 464, 436-440.
DOI
ScienceOn
|
| 43 |
Kucherlapati, R. (2012) Genetically modified mouse models for biomarker discovery and preclinical drug testing. Clin. Cancer Res. 18, 625-630.
DOI
ScienceOn
|
| 44 |
Lewandoski, M. (2001) Conditional control of gene expression in the mouse. Nat. Rev. Genet. 2, 743-755.
DOI
ScienceOn
|
| 45 |
Mackay, G. E. and West, J. D. (2005) Fate of tetraploid cells in 4n<->2n chimeric mouse blastocysts. Mech. Dev. 122, 1266-1281.
DOI
ScienceOn
|
| 46 |
Palais, G., Nguyen Dinh Cat, A., Friedman, H., Panek-Huet, N., Millet, A., Tronche, F., Gellen, B., Mercadier, J. J., Peterson, A. and Jaisser, F. (2009) Targeted transgenesis at the HPRT locus: an effi cient strategy to achieve tightly controlled in vivo conditional expression with the tet system. Physiol. Genomics 37, 140-146.
DOI
ScienceOn
|
| 47 |
McJunkin, K., Mazurek, A., Premsrirut, P. K., Zuber, J., Dow, L. E., Simon, J., Stillman, B. and Lowe, S. W. (2011) Reversible suppression of an essential gene in adult mice using transgenic RNA interference. Proc. Natl. Acad. Sci. U.S.A. 108, 7113-7118.
DOI
ScienceOn
|
| 48 |
Ohta, H., Sakaide, Y. and Wakayama, T. (2008) Generation of mice derived from embryonic stem cells using blastocysts of different developmental ages. Reproduction 136, 581-587.
DOI
ScienceOn
|
| 49 |
Paddison, P. J., Caudy, A. A. and Hannon, G. J. (2002) Stable suppression of gene expression by RNAi in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99, 1443-1448.
DOI
ScienceOn
|
| 50 |
Politi, K. and Pao, W. (2011) How genetically engineered mouse tumor models provide insights into human cancers. J. Clin. Oncol. 29, 2273-2281.
DOI
ScienceOn
|
| 51 |
Prawitt, D., Brixel, L., Spangenberg, C., Eshkind, L., Heck, R., Oesch, F., Zabel, B. and Bockamp, E. (2004) RNAi knock-down mice: an emerging technology for post-genomic functional genetics. ytogenet. Genome Res. 105, 412-421.
DOI
ScienceOn
|
| 52 |
Premsrirut, P. K., Dow, L. E., Kim, S. Y., Camiolo, M., Malone, C. D., Miething, C., Scuoppo, C., Zuber, J., Dickins, R. A., Kogan, S. C., Shroyer, K. R., Sordella, R., Hannon, G. J. and Lowe, S. W. (2011) A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell 145, 145-158.
DOI
ScienceOn
|
| 53 |
Gaj, T., Gersbach, C. A. and Barbas C. F. 3rd. (2013) ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 31, 397-405.
DOI
ScienceOn
|
| 54 |
Seibler, J., Zevnik, B., Kuter-Luks, B., Andreas, S., Kern, H., Hennek, T., Rode, A., Heimann, C., Faust, N. and Kauselmann, G. (2003) Rapid generation of inducible mouse mutants. Nucleic Acids Res. 31, e12.
DOI
ScienceOn
|
| 55 |
McCreath, K., Howcroft, J., Campbell, K., Colman, A., Schnieke, A. and Kind, A. (2000) Production of gene-targeted sheep by nuclear transfer from cultured somatic cells. Nature 405, 1066-1069.
DOI
ScienceOn
|
webmaster
